|

Interview With Ronan Levy

ByPsychedelic Spotlight
Ronan Levy

Similar Posts

  • How Risky is MindMed Stock? (MMED / MMEDF Risk Assessment)

    Listen, Videos

    Today, we have a different episode for you..Usually we talk about all the things I am excited for when it comes to MindMed and MindMed stock, but today, we will visit the darker side by discussing how risky is the MindMed stock.
    It is important for all psychedelic investors to grasp that MindMed is not a sure deal. Yes, I believe that long term it will succeed, but there are certain things that could go wrong.

    We will cover the very real risks involved in investing in MindMed such as:
    1. The possibility of MindMed’s medicines being inefficacious
    – Whether of not MMED’s clinical trials succeed
    2.MindMed’s incertain long term profitability
    – Can the company scale production and training protocols?
    3.MindMed Stock volatility
    – MindMed’s market cap
    – Future short interests

    MindMed trades on the Canadian NEO Market as (MMED) and American OTC market as (MMEDF)

    MindMed is the leader in psychedelic medicines, and is my top Psychedelic Stock. Is MindMed a buy? Is MindMed a good Investment? Watch our channel to find out!

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!

    Follow us on social media!
    Instagram: @psychedelicinvestor
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com

    https://mindmed.co/wp-content/uploads/2020/11/end-of-year-2019-discussion.pdf

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own